RecruitingNCT03893136

The Registry Study of Takayasu Arteritis in East China

Studying Takayasu arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Zhongshan Hospital
Principal Investigator
Lindi Jiang, PhD
Fudan University
Intervention
Tocilizumab(biological)
Enrollment
1000 enrolled
Eligibility
18-65 years · All sexes
Timeline
20162026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03893136 on ClinicalTrials.gov

Other trials for Takayasu arteritis

Additional recruiting or active studies for the same condition.

See all trials for Takayasu arteritis

← Back to all trials